Repligen (RGEN) PT Lowered to $145 at Canaccord
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $140.51 +2.98%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 23
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 23
Join SI Premium – FREE
Canaccord analyst Kyle Mikson lowered the price target on Repligen (NASDAQ: RGEN) to $145.00 (from $165.00) while maintaining a Hold rating.
You May Also Be Interested In
- X-Energy Inc (XE) PT Lowered to $34 at UBS
- Osaka Organic Chemical Industry Ltd (4187:JP) PT Raised to JPY7,400 at Morgan Stanley
- United Rentals (URI) PT Raised to $1,300 at UBS on Increased Conviction in Non-Res Rebound
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
